NYSE:TFX - Teleflex Stock Price, Forecast & News

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Teleflex announced a quarterly dividend on Thursday, February 20th. Investors of record on Monday, March 2nd will be given a dividend of $0.34 per share on Monday, March 16th. This represents a $1.36 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Friday, February 28th. View Teleflex's Dividend History.

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings results on Thursday, February, 20th. The medical technology company reported $3.28 EPS for the quarter, topping the consensus estimate of $3.22 by $0.06. The medical technology company earned $681 million during the quarter, compared to the consensus estimate of $679.01 million. Teleflex had a net margin of 17.78% and a return on equity of 18.97%. The business's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.77 EPS. View Teleflex's Earnings History.

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, May 7th 2020. View Earnings Estimates for Teleflex.

Teleflex updated its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of $12.50-12.70 for the period, compared to the Thomson Reuters consensus estimate of $12.68. The company issued revenue guidance of $2.764-2.790 billion, compared to the consensus revenue estimate of $2.78 billion.

10 Wall Street analysts have issued 12 month price objectives for Teleflex's shares. Their forecasts range from $365.00 to $450.00. On average, they anticipate Teleflex's share price to reach $412.55 in the next year. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Teleflex.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teleflex.

Press coverage about TFX stock has trended very positive recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teleflex earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news coverage about the medical technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Teleflex.

Teleflex saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 638,200 shares, a drop of 15.6% from the January 15th total of 755,900 shares. Based on an average daily trading volume, of 228,600 shares, the short-interest ratio is currently 2.8 days. Approximately 1.4% of the shares of the company are sold short. View Teleflex's Current Options Chain.

Some companies that are related to Teleflex include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Steris (STE), Hologic (HOLX), Insulet (PODD) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include Visa (V), AbbVie (ABBV), Alibaba Group (BABA), Netflix (NFLX), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH), ABIOMED (ABMD), Alphabet (GOOG) and Intuitive Surgical (ISRG).

Teleflex's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (4.12%), Janus Henderson Group PLC (1.95%), Marshall Wace LLP (1.57%), Geode Capital Management LLC (1.56%), William Blair Investment Management LLC (1.48%) and Goldman Sachs Group Inc. (1.24%). Company insiders that own Teleflex stock include Andrew A Krakauer, Benson Smith, Cameron P Hicks, George Babich Jr, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle, Thomas Anthony Kennedy and Thomas E Powell. View Institutional Ownership Trends for Teleflex.

TFX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Marshall Wace LLP, Janus Henderson Group PLC, Rice Hall James & Associates LLC, Principal Financial Group Inc., Marshall Wace North America L.P., FIL Ltd and USS Investment Management Ltd. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell. View Insider Buying and Selling for Teleflex.

TFX stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Montag & Caldwell LLC, Scout Investments Inc., AMI Asset Management Corp, Lord Abbett & CO. LLC, Victory Capital Management Inc., Kornitzer Capital Management Inc. KS and Victory Capital Management Inc.. Company insiders that have bought Teleflex stock in the last two years include Andrew A Krakauer and John C Heinmiller. View Insider Buying and Selling for Teleflex.

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TFX stock can currently be purchased for approximately $370.40.

Teleflex has a market capitalization of $17.15 billion and generates $2.60 billion in revenue each year. The medical technology company earns $200.80 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 15,200 workers across the globe.View Additional Information About Teleflex.

The official website for Teleflex is http://www.teleflex.com/.

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]